Breaking News

Eye Drop Proven to Slow Myopia Progression in Children
Eye Drop Proven to Slow Myopia Progression in Children Jun 02, 2023 The findings from a recent clinical trial indicate that a potential breakthrough drug therapy, aimed at slowing down the advancement of nearsightedness in children, may be within reach.
Revolutionary Gene Therapy Restores Sight to Child with LCA
Revolutionary Gene Therapy Restores Sight to Child with LCA May 30, 2023 In a remarkable medical breakthrough, two retinologist surgeons at the Maisonneuve-Rosemont Hospital ophthalmology clinic have successfully performed groundbreaking gene therapy on an 11-year-old boy.
FTC Files Lawsuit to Block Amgen's Acquisition of Horizon Therapeutics
FTC Files Lawsuit to Block Amgen's Acquisition of Horizon Therapeutics May 23, 2023 The US Federal Trade Commission has filed a lawsuit with the intention of preventing Amgen's $27.8 billion acquisition of Horizon Therapeutics.

 

Industry News

Vivavision’s Ophthalmic Solution Significantly Reduces IOP in Phase II Study
Vivavision’s Ophthalmic Solution Significantly Reduces IOP in Phase II Study Jun 06, 2023 Vivavision Biotech announced that its Phase IIa first-in-human trial of VVN539 Ophthalmic Solution in the US has met its primary study endpoints.
Gamesquare Collaborates with Vivior to Promote Healthy Screen Habits for Gamers
Gamesquare Collaborates with Vivior to Promote Healthy Screen Habits for Gamers Jun 05, 2023 GameSquare Holdings and Swiss vision care startup Vivior have entered into a substantial multi-year partnership, aimed at fostering healthy digital habits, as per the official news release by the company.
Aviceda Initiates Clinical Trial for AVD-104, a Breakthrough Glyco-Mimetic Nanoparticle in GA Treatment
Aviceda Initiates Clinical Trial for AVD-104, a Breakthrough Glyco-Mimetic Nanoparticle in GA Treatment Jun 05, 2023 Aviceda Therapeutics has kicked off its phase 2 SIGLEC trial, with the dosing of the first patient using AVD-104 for the treatment of geographic atrophy (GA).

Ophthalmic Research News

Breakthrough in Ophthalmology: Study Reveals the Dynamic Structure of the Human Eye
Breakthrough in Ophthalmology: Study Reveals the Dynamic Structure of the Human Eye Jun 02, 2023 A recent study in the journal Genes & Diseases by researchers from Sichuan Provincial People's Hospital sheds light on degenerative processes within the human RPE and choroid while identifying potential therapeutic targets.
Automated Algorithm Predicts Retinopathy Progression in Diabetic Patients
Automated Algorithm Predicts Retinopathy Progression in Diabetic Patients Jun 01, 2023 According to a study published in JAMA Ophthalmology, researchers from the Chinese University of Hong Kong, led by Dawei Yang, Ph.D., investigated the prognostic value of an automated binary diabetic macular ischemia (DMI) algorithm OCTA.
Experimental Drug Found Effective in Preventing Diabetic Eye Disease
Experimental Drug Found Effective in Preventing Diabetic Eye Disease May 26, 2023 Researchers at the Wilmer Eye Institute, Johns Hopkins Medicine, have recently unveiled compelling evidence suggesting that an experimental drug shows promise in preventing or slowing down vision loss among individuals with diabetes.

Ophthalmic Blog

An Asymmetrical Gaze: A Closer Look at Relative Afferent Pupillary Defect
An Asymmetrical Gaze: A Closer Look at Relative Afferent Pupillary Defect Jun 06, 2023 Relative Afferent Pupillary Defect (RAPD), also known as Marcus Gunn pupil, is a fascinating physiological anomaly that sheds light on the intricate interplay between light, vision, and our nervous system.
7 Tips to Determine if Contact Lenses Are Right for You
7 Tips to Determine if Contact Lenses Are Right for You Jun 05, 2023 Contact lenses provide an alternative to traditional eyeglasses, offering convenience, improved peripheral vision, and freedom from frames. However, they may not be suitable for everyone.
Unraveling the Red Nodule: Exploring Capillary Hemangioma
Unraveling the Red Nodule: Exploring Capillary Hemangioma Jun 05, 2023 Capillary hemangioma, an intriguing anomaly, serves as a prime example of how our understanding of the human eye continues to expand. This benign tumor originates from an overgrowth of capillaries leading to the formation of abnormal blood vessels.
Ophthalmology Breaking News Subscribe